Obesity-Independent Association between Glycemic Status and the Risk of Hematologic Malignancy: A Nationwide Population-Based Longitudinal Cohort Study

There have been conflicting results regarding the association between diabetes and the risk of hematologic malignancies, and its interaction with obesity is unknown. This study determined the risk of hematologic malignancies according to the glycemic status in a population-based study involving heal...

Full description

Bibliographic Details
Main Authors: Jihun Kang, Sang-Man Jin, Seok Jin Kim, Dahye Kim, Kyungdo Han, Su-Min Jeong, JiWon Chang, Sang Youl Rhee, Taewoong Choi, Dong Wook Shin
Format: Article
Language:English
Published: MDPI AG 2021-09-01
Series:Cancers
Subjects:
Online Access:https://www.mdpi.com/2072-6694/13/19/4760
_version_ 1797516752081387520
author Jihun Kang
Sang-Man Jin
Seok Jin Kim
Dahye Kim
Kyungdo Han
Su-Min Jeong
JiWon Chang
Sang Youl Rhee
Taewoong Choi
Dong Wook Shin
author_facet Jihun Kang
Sang-Man Jin
Seok Jin Kim
Dahye Kim
Kyungdo Han
Su-Min Jeong
JiWon Chang
Sang Youl Rhee
Taewoong Choi
Dong Wook Shin
author_sort Jihun Kang
collection DOAJ
description There have been conflicting results regarding the association between diabetes and the risk of hematologic malignancies, and its interaction with obesity is unknown. This study determined the risk of hematologic malignancies according to the glycemic status in a population-based study involving health screening 9,774,625 participants. The baseline glycemic status of the participants was categorized into no diabetes, impaired fasting glucose (IFG), newly detected diabetes, diabetes duration <5 years, and diabetes duration ≥5 year groups. The risks of overall and specific hematologic malignancies were estimated using a Cox regression analysis. During a median follow up of 7.3 years, 14,733 hematologic malignancies developed. The adjusted hazard ratio (aHR) for the risk of all the hematologic malignancies was 0.99 (95% confidence interval (CI) 0.95–1.02) for IFG, 0.99 (95% CI 0.91–1.08) for newly detected diabetes, 1.03 (95% CI 0.96–1.11) for diabetes duration <5 years, and 1.11 (95% CI 1.03, 1.20) for diabetes duration ≥5 year groups. The association was independent from obesity. The risk of non-Hodgkin’s lymphoma (NHL) increased according to the progression of dysglycemia towards a longer diabetes duration, while Hodgkin’s lymphoma did not. This study in Korea demonstrated diabetes to be associated with an increased risk of hematologic malignancies independent of obesity. The NHL risk increased with the diabetes duration.
first_indexed 2024-03-10T07:06:10Z
format Article
id doaj.art-e0f9d06ffc1d41ef9e4b323b6fe134b3
institution Directory Open Access Journal
issn 2072-6694
language English
last_indexed 2024-03-10T07:06:10Z
publishDate 2021-09-01
publisher MDPI AG
record_format Article
series Cancers
spelling doaj.art-e0f9d06ffc1d41ef9e4b323b6fe134b32023-11-22T15:51:56ZengMDPI AGCancers2072-66942021-09-011319476010.3390/cancers13194760Obesity-Independent Association between Glycemic Status and the Risk of Hematologic Malignancy: A Nationwide Population-Based Longitudinal Cohort StudyJihun Kang0Sang-Man Jin1Seok Jin Kim2Dahye Kim3Kyungdo Han4Su-Min Jeong5JiWon Chang6Sang Youl Rhee7Taewoong Choi8Dong Wook Shin9Department of Family Medicine, Kosin University Gospel Hospital, Kosin University College of Medicine, Busan 49267, KoreaDivision of Endocrinology and Metabolism, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul 06351, KoreaDivision of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul 06351, KoreaDepartment of Medical Statistics, The Catholic University of Korea, Seoul 03083, KoreaDepartment of Statistics and Actuarial Science, Soongsil University, Seoul 06978, KoreaDepartment of Family Medicine, Boramae Medical Center, Seoul Metropolitan Government-Seoul National University, Seoul 07061, KoreaSupportive Care Center, Samsung Medical Center, Seoul 06351, KoreaDepartment of Endocrinology and Metabolism, Kyung Hee University School of Medicine, Seoul 02453, KoreaDivision of Hematologic Malignancies and Cellular Therapy, Duke University Medical Center, Durham, NC 27710, USASupportive Care Center, Samsung Medical Center, Seoul 06351, KoreaThere have been conflicting results regarding the association between diabetes and the risk of hematologic malignancies, and its interaction with obesity is unknown. This study determined the risk of hematologic malignancies according to the glycemic status in a population-based study involving health screening 9,774,625 participants. The baseline glycemic status of the participants was categorized into no diabetes, impaired fasting glucose (IFG), newly detected diabetes, diabetes duration <5 years, and diabetes duration ≥5 year groups. The risks of overall and specific hematologic malignancies were estimated using a Cox regression analysis. During a median follow up of 7.3 years, 14,733 hematologic malignancies developed. The adjusted hazard ratio (aHR) for the risk of all the hematologic malignancies was 0.99 (95% confidence interval (CI) 0.95–1.02) for IFG, 0.99 (95% CI 0.91–1.08) for newly detected diabetes, 1.03 (95% CI 0.96–1.11) for diabetes duration <5 years, and 1.11 (95% CI 1.03, 1.20) for diabetes duration ≥5 year groups. The association was independent from obesity. The risk of non-Hodgkin’s lymphoma (NHL) increased according to the progression of dysglycemia towards a longer diabetes duration, while Hodgkin’s lymphoma did not. This study in Korea demonstrated diabetes to be associated with an increased risk of hematologic malignancies independent of obesity. The NHL risk increased with the diabetes duration.https://www.mdpi.com/2072-6694/13/19/4760hematologic malignanciesHodgkin’s lymphomanon-Hodgkin’s lymphomadiabetesglycemic status
spellingShingle Jihun Kang
Sang-Man Jin
Seok Jin Kim
Dahye Kim
Kyungdo Han
Su-Min Jeong
JiWon Chang
Sang Youl Rhee
Taewoong Choi
Dong Wook Shin
Obesity-Independent Association between Glycemic Status and the Risk of Hematologic Malignancy: A Nationwide Population-Based Longitudinal Cohort Study
Cancers
hematologic malignancies
Hodgkin’s lymphoma
non-Hodgkin’s lymphoma
diabetes
glycemic status
title Obesity-Independent Association between Glycemic Status and the Risk of Hematologic Malignancy: A Nationwide Population-Based Longitudinal Cohort Study
title_full Obesity-Independent Association between Glycemic Status and the Risk of Hematologic Malignancy: A Nationwide Population-Based Longitudinal Cohort Study
title_fullStr Obesity-Independent Association between Glycemic Status and the Risk of Hematologic Malignancy: A Nationwide Population-Based Longitudinal Cohort Study
title_full_unstemmed Obesity-Independent Association between Glycemic Status and the Risk of Hematologic Malignancy: A Nationwide Population-Based Longitudinal Cohort Study
title_short Obesity-Independent Association between Glycemic Status and the Risk of Hematologic Malignancy: A Nationwide Population-Based Longitudinal Cohort Study
title_sort obesity independent association between glycemic status and the risk of hematologic malignancy a nationwide population based longitudinal cohort study
topic hematologic malignancies
Hodgkin’s lymphoma
non-Hodgkin’s lymphoma
diabetes
glycemic status
url https://www.mdpi.com/2072-6694/13/19/4760
work_keys_str_mv AT jihunkang obesityindependentassociationbetweenglycemicstatusandtheriskofhematologicmalignancyanationwidepopulationbasedlongitudinalcohortstudy
AT sangmanjin obesityindependentassociationbetweenglycemicstatusandtheriskofhematologicmalignancyanationwidepopulationbasedlongitudinalcohortstudy
AT seokjinkim obesityindependentassociationbetweenglycemicstatusandtheriskofhematologicmalignancyanationwidepopulationbasedlongitudinalcohortstudy
AT dahyekim obesityindependentassociationbetweenglycemicstatusandtheriskofhematologicmalignancyanationwidepopulationbasedlongitudinalcohortstudy
AT kyungdohan obesityindependentassociationbetweenglycemicstatusandtheriskofhematologicmalignancyanationwidepopulationbasedlongitudinalcohortstudy
AT suminjeong obesityindependentassociationbetweenglycemicstatusandtheriskofhematologicmalignancyanationwidepopulationbasedlongitudinalcohortstudy
AT jiwonchang obesityindependentassociationbetweenglycemicstatusandtheriskofhematologicmalignancyanationwidepopulationbasedlongitudinalcohortstudy
AT sangyoulrhee obesityindependentassociationbetweenglycemicstatusandtheriskofhematologicmalignancyanationwidepopulationbasedlongitudinalcohortstudy
AT taewoongchoi obesityindependentassociationbetweenglycemicstatusandtheriskofhematologicmalignancyanationwidepopulationbasedlongitudinalcohortstudy
AT dongwookshin obesityindependentassociationbetweenglycemicstatusandtheriskofhematologicmalignancyanationwidepopulationbasedlongitudinalcohortstudy